We Dissect Protocols

1100 hplc system

Manufactured by Agilent Technologies
655 citations
Sourced in United States, Germany, Canada, Ireland, United Kingdom, China, Japan, France, Italy
About the product

The 1100 HPLC system is a high-performance liquid chromatography (HPLC) instrument manufactured by Agilent Technologies. The system is designed to separate, identify, and quantify various chemical compounds in a liquid sample.

Automatically generated - may contain errors

Market Availability & Pricing

The Agilent 1100 HPLC system has been discontinued by Agilent Technologies and is no longer available through official channels. Refurbished and used units may be available through third-party vendors, but pricing can vary widely depending on the condition and configuration. Agilent recommends the Infinity II LC as the successor to the 1100 system.

Need Operating Instructions, SDS, or distributor details? Just ask our AI Agent.

Is this product still available?

Get pricing insights and sourcing options

655 protocols using «1100 hplc system»

1

Quantification of CTX by RP-HPLC

2025
CTX was analyzed using RP-HPLC equipped on an Agilent 1100 HPLC system (Waldbronn, Germany) with an autosampler, a Varian C18 column (250 × 4.6 mm), and a Diode Array Detector (Atlas). The mobile phase consisted of a combination of acetonitrile (ACN) and deionized water in a 55:45% v/v ratio. An isocratic separation method was employed with 1 mL/min and 25 °C for flow rate and column temperature, respectively. A 20 µL injection volume was used, and the run time was 7 min. CTX had a retention time of 1.7 min and was detected at an absorption wavelength (λmax) of 270 nm. CTX standards were prepared by serial dilution in deionized water at concentrations between 25 and 250 µg/mL, were analyzed in triplicate (n = 3), and a calibration curve was generated by correlating the mean peak area against the concentration.
+ Open protocol
+ Expand
2

Quantitative Analysis of PFAS Compounds

2025
Quantitative analysis of PFOA, PFNA, and PFOS was conducted using a Waters Micromass Quattro Ultima quadrupole mass spectrometer (Milford, MA, USA) coupled with an Agilent 1100 HPLC system. An Xterra MS C18 analytical column (150 mm × 4.6 mm; 5.0 μm particle size, from Waters (Milford, MA, USA)) and a Phenomenex delay column (50 mm × 4.6 mm; 3.0 μm particle size, from Phenomenex (Torrance, CA, USA)) were used. The instrument was operated in ESI negative mode, and the data were acquired in multiple reaction monitoring mode.
+ Open protocol
+ Expand
3

Proteomic Analysis of HA-EZH2 Complex

2025
Lysates of the HA-EZH2 transfected RPMI8226 cells were pulled down with anti-HA agarose and subjected to SDS-PAGE gel. Gel bands stained with Coomassie blue were excised separately, alkylated, and digested with trypsin. The tryptic peptides were then analyzed using a nano-LC/MS/MS (Thermo Fisher Scientific) coupled with an 1100 HPLC system (Agilent Technologies). The MS/MS spectra were searched using the SEQUEST software program with the BioWorks Browser (version 3.3.1; Thermo Fisher Scientific) against the NCBI database. RPMI8226 cells transfected with an empty vector were used as controls.
+ Open protocol
+ Expand
4

Peptide Separation and Quantification by LC-MS/MS

2025
After desalting, peptides were separated on an 1100 HPLC System (Agilent) using an Agilent Zorbax Extend reversed-phase column (5 μm, 150 mm × 2.1 mm) at a flow rate of 250 ul/min and gradient elution was performed according to the following method [preparation of phase A (ACN-H2O (2: 98, v/v) and phase B (ACN-H2O (90: 10, v/v)]: 0 ~ 10 min, 2% B; 10 ~ 10.01 min, 2–5% B; 10.01–37 min, 5–20% B; 37–48 min, 20–40% B; 48–48.01 min, 40–90% B; 48.01–58 min, 90% B; 58–58.01 min, 90–2% B; 58.01–63 min, 2% B.
All analyses were performed by a Q-Exactive HF mass spectrometer (Thermo, USA) equipped with a Nanospray Flex source (Thermo, USA). Samples were loaded and separated by a C18 column (50 cm × 75 µm) on an EASY-nLC™ 1200 system (Thermo, USA). The flow rate was 300 nL/min and linear gradient was 90 min (0 ~ 60 min, 8–25% B; 60 ~ 79 min, 25–45% B; 79 ~ 80 min, 45–100% B; 80 ~ 90 min, 100% B; mobile phase A = 0.1% FA in water and B = 0.1% FA in 80%ACN).
For DDA parameters, the full MS scans were acquired in the mass range of 350–1650 m/z with a mass resolution of 120,000 and the automatic gain control (AGC) target value was set at 3 × 106. The 20 most intense peaks in MS were fragmented with higher-energy collisional dissociation (HCD) with a collision energy of 27. MS/MS spectra were obtained with a resolution of 30,000 with an AGC target of 2 × 105 and a max injection time of 80 ms. The Q Exactive HF dynamic exclusion was set for 40.0 s and run under positive mode.
For DIA parameters, the full MS scans were acquired in the mass range of 350–1250 m/z with a mass resolution of 120,000 and the AGC target value was set at 3 × 106. The 32 acquisition windows in MS were fragmented with HCD with a collision energy of 28, and each acquisition window has 26 m/z. MS/MS spectra were obtained with a resolution of 30,000 with an AGC target of 1 × 106, and the maximum injection time was set to auto and run under positive mode.
+ Open protocol
+ Expand
5

Chiral HPLC Analysis of Pharmaceuticals

2025
The chiral HPLC experiments were carried out on Agilent 1100 HPLC system, consisting of an inline degasser (G1322A), a quaternary pump (G1311A), an automatic injector (G1329A) paired with sample thermostat (G1330A), a column thermostat (G1316A), and a diode array detector (G1315A) with Agilent Chemstation B04.03-SP2 software (Agilent, Bronnwald, Germany). Chromatographic analysis was performed at 25 °C with a mobile phase flow rate of 0.7 mL/min in polar organic mode.
The chromatography screening study was performed at 25 °C on polysaccharide type Chiracel OD, Chiralpak AD, Chiralpak IA with identical dimensions (250 × 4.6 mm; particle size 10 µm) and CD-based, Astec Cyclobond I 2000 (250 × 4.6 mm; particle size 10 µm), Nucleodex Beta-PM (200 × 4.0 mm; particle size 5 µm), Chiral CD-Ph (250 × 4.6 mm; particle size 10 µm) chiral columns with a mobile phase flow rate 0.7 mL/min. Isocratic elution was applied using ACN:DEA 100:0.1 and MeOH:DEA 100:0.1 as eluent. The injection volume was 2 µL. The detection wavelength was 270 nm. Sample preparation: 1 mg/mL stock solution in MeOH.
For semi-preparative scale separation of PROP Chiralpak AD column (10 µm, 250 × 10 mm), while for semi-preparative separation of LAU and Br-LAU Chiralcel OD column (10 µm, 250 × 10 mm) was used using uniformly MeOH:DEA 100:0.1 eluent at 30 °C.
The injection volume was 20 µL using 100 parallel measurements. Sample preparation: 20 mg/mL stock solution in MeOH.
+ Open protocol
+ Expand

Top 5 most cited protocols using «1100 hplc system»

1

Quantitative Analysis of Polycyclic Aromatic Hydrocarbons

Samples were prepared and analyzed as follows: 250 mg whole blood were spiked with 5 μL of an 8.6 μM B[a]P solution as an internal standard. 250 μL 0.9 M sulfuric acid and 250 mg sodium sulfate were added to each sample, and vortex mixed for 30 seconds. The samples were then thrice extracted with 0.5 mL ethyl acetate and centrifuged for 10 minutes at 1400 × g, and the combined supernatant of each sample evaporated to dryness under a gentle stream of nitrogen. Samples were reconstituted in 100 μL methanol.
DBC and B[a]P were quantitated by reverse phase high pressure liquid chromatography (HPLC) using an Agilent 1100 HPLC system (Santa Clara, CA, USA) equipped with a fluorescence detector. 20 uL of reconstituted sample were injected onto an Ascentis 25 cm × 4.6 mm, 5 μm C18 column (Sigma Aldrich, St. Louis, MO, USA). A water:acetonitrile gradient from 45:55 to 0:100 was employed from 0 to 10 minutes, and then held at 100% acetonitrile until 22 minutes, at a constant flow rate of 0.95 mL/min. Excitation and emission wavelengths were 245 and 430 for 11,12,13,14-DBC tetraols, and 360 and 430 for 11,12-DBC diol, and 235 and 430 for B[a]P and DBC. Elution times were 5.5, 6.1, and 6.6 min for 11,12,13,14-DBC tetraols, 10.4 min for 11,12-DBC diol, 16.6 min for B[a]P, and 19.0 min for DBC. The limits of reliable quantitation (LOQ) for DBC were 0.0026 – 3.8 μM.
+ Open protocol
+ Expand

Corresponding organizations : Pacific Northwest National Laboratory, Pennsylvania State University, Oregon State University

2

HPLC Quantification of PAH Metabolites

DBC, B[a]P, and their hydroxylated metabolites were quantified by reverse-phase
HPLC using an Agilent 1100 HPLC system equipped with a fluorescence detector (Santa Clara,
CA, USA). Twenty μL of reconstituted sample were injected onto an Ascentis 25 cm
× 4.6 mm, 5 μm C18 column (Sigma–Aldrich, St. Louis, MO,
USA). A water:acetonitrile gradient from 45:55 to 0:100 was employed from 0 to 10 min, and
then held at 100% acetonitrile until 22 min, at a constant flow rate of 0.95 mL/min.
Excitation and emission wavelengths were 245 and 430 for tetraol metabolites, 360 and 430
for diol metabolites, and 235 and 430 for B[a]P and DBC. Elution times were 20.9 and 18.1
min for DBC and B[a]P, 10.7 and 8.5 min for DBC-diol and B[a]P-diol, 5.4, 6.0, and 6.6 min
for DBC tetraols, and 3.3, 3.9, and 4.6 min for B[a]P tetraols. The limits of reliable
quantitation (LOQ) for B[a]P and DBC were 0.0.04 and 0.02 μM, respectively.
+ Open protocol
+ Expand

Corresponding organizations : Pacific Northwest National Laboratory, Oregon State University

3

Pharmacokinetics of Compound 12 in Rats

Male Sprague–Dawley rats aged 8 weeks at time of dosing were acquired from Charles River Laboratories and were dosed orally. Three to four animals were used per time point. Dose was formulated in food-grade corn oil at 10 mg/kg. Plasma, liver, and brain were taken from all rats at 0.5, 1, 2, 4, and 8 h postdose. Samples were prepared and analyzed as follows: Plasma (50 μL) was mixed with 10 μL of 10 μL of acetonitrile, and 300 μL of acetonitrile, vortexed, and centrifuged at 9000g for 5 min. Supernatants were transferred to autosampler vials with low-volume inserts and injected without dilution. Brains were homogenized with 50:50 ethanol/water (3:1, v/v) using a Potter Elvehjem type homogenizer. Homogenate (50 μL) was mixed with 10 μL of acetonitrile, and 300 μL of acetonitrile, vortexed and centrifuged at 9000g for 5 min. Supernatant was transferred to autosampler vials with low-volume inserts and injected without dilution. Standards were prepared as above for each compound in blank plasma, blank liver homogenate, and blank brain homogenate. Standards used were within 15% of nominal; except for 20% at LOQ. Compounds for LC-MS/MS analyses were supplied at 1 mg/mL in methanol. The stock solutions were further diluted to ∼100 ng/mL. The 100 ng/mL solutions were used to optimize the mass spectrometer for MRM transitions and mass spectrometer parameters. Infusion and flow injection optimization were also performed. LC-MS/MS was conducted using an Applied Biosystems API 4000 coupled with an Agilent 1100 HPLC system. Chromatography was performed with a Phenomenex Luna C18 (50 × 2 mm, 5 μm) column. Mobile phases were 0.1% formic acid and 10 mM ammonium formate in water (A), and 0.1% formice acid and 10 mM ammonium formate in methanol. Initial conditions were 10% B and held for one minute, followed by a linear gradient to 90% B over 5 min. 90% B was held for 2 min before returning to initial conditions. Compound 12 was analyzed with multiple reaction monitoring in the positive mode with a transition of 595.28 → 370.0. The following parameters were used, DP = 116, CE = 45, CXP = 36, CAD = 4, CUR = 10, GS1 = 40, GS2 = 60, IS = 4000, and TEM = 650.
+ Open protocol
+ Expand

Corresponding organizations : RTI International

4

ERLIC Fractionation for Enhanced Proteomics

ERLIC fractionation was performed as previously described31 (link) with slight modifications. We used the concatenated ERLIC pooled strategy as it was shown that the number of unique peptides identified in concatenated ERLIC is significantly higher than pooling adjacent fractions using the same LC-MS/MS gradient32 (link). Briefly, trypsin or LysC-derived peptides generated from 1 mg of protein were dissolved in 100 μL of 80% (v/v) loading buffer (10 mM NH4Ac, 85% ACN/1% acetic acid), injected completely with an auto-sampler, and fractionated using a PolyWAX LP anion-exchange column (200 × 3.2 mm, 5 μm, 300 Å; PolyLC, Columbia, MD) on an Agilent 1100 HPLC system monitored at 280 nm. Forty fractions were collected with a 66-min gradient of 100% mobile phase A (90% ACN/0.1% acetic acid) for 3 min, 0%–20% mobile phase B (30% ACN/0.1% FA) for 50 min, 20%–100% B for 5 min, followed by 8 min at 100% B at a flow rate of 0.3 ml/min. The 40 fractions were pooled into 20 fractions by combining in the following manner, (1, 40); (2, 39); (3, 38), and so on.
+ Open protocol
+ Expand
5

HPLC-ESI-MS Analysis of Olive Oil Polyphenols

The extraction of the polar compounds from the selected EVOOs was performed after 6 months of bottle storage, using a 80:20 (v/v) methanol/water mixture according to a previously published procedure [11 (link)]. Separation and identification of polyphenols were carried out by using a HPLC 1100 system equipped with a degasser, quaternary pump solvent delivery, thermostatic column compartment, autosampler, single wavelength UV-Vis detector, and MSD triple quadrupole QQQ 6430 in a series configuration (Agilent Technologies, Palo Alto, CA, USA). Briefly, after filtration through 0.2 m pore size regenerated cellulose filters (VWR International Srl, Milano, Italy), EVOO extracts were injected onto a reversed stationary phase column, Luna C18 (150 × 2 mm i.d., particle size 3 µm, Phenomenex, Torrance, CA, USA) protected by a C18 Guard Cartridge (4.0 × 2.0 mm i.d., Phenomenex). HPLC separation was accomplished using a binary mobile phase composed of (solvent A) water containing 0.1% (v/v) formic acid and (solvent B) acetonitrile (Chromasolv, VWR International Srl, Milano, Italy). The following gradient was adopted: 0 min, 10% B; 1 min, 10% B; 15 min, 30% B; 22 min, 50% B; 28 min, 100% B; 34 min, 100% B; 36 min, 10% B, followed by washing and re-equilibrating the column (with ~20 column volume). The column temperature was controlled at 25 °C, and the flow was maintained at 0.4 mL/min. UV-Vis detection wavelength was set at 280 nm.
Ionization of the molecules was acquired in negative ESI mode with capillary voltage at 4000 V, using nitrogen as drying (T = 350 °C; flow rate = 9 L/min) and nebulizing gas (40 psi). The mass acquisition in MS and MS/MS spectra ranged between m/z 50 and 1200. All data were acquired and processed using Mass Hunter Workstation software (version B.01.04; Agilent Technologies). Typically, two runs were performed during the HPLC-ESI-MS analysis of each sample. First, an MS full-scan acquisition was performed to obtain preliminary information on the predominant m/z ratios observed during the elution. Subsequently, MS/MS spectra were acquired: quadrupole 1 filtered the calculated m/z of each compound of interest, while quadrupole 3 scanned for ions produced by nitrogen collision of these ionized compounds in the chosen range at a scan time of 500 ms/cycle.
Tentative compound identification was achieved by combining different information: UV absorption, retention times (RT), and mass spectra (MS and MS/MS) which were compared with those from pure standards, when available, and/or interpreted with the help of structural models already hypothesized in the literature [11 (link),36 (link),37 (link)]. Then, the main revealed compounds were quantified by multiple reaction monitoring (MRM) as 3-hydroxytyrosol (R2 = 0.99923; LOD = 0.0033 µg/g; LOQ = 0.0113 µg/g) and tyrosol (R2 = 0.99904; LOD = 0.0041 µg/g; LOQ = 0.0125 µg/g) equivalents in the case of aromatic alcohols and secoiridoids, apigenin (R2 = 0.99937; LOD = 0.0028 µg/g; LOQ = 0.0108 µg/g) equivalents in the case of flavonoids, and pinoresinol (R2 = 0.99889; LOD = 0.0054 µg/g; LOQ = 0.0152 µg/g) equivalents in the case of lignans. The optimized parameters (fragmentor voltage and collision energy) for each selected compound together with the mass transitions adopted for MRM were acquired through Mass Hunter Optimizer software (version B.03.01; Agilent Technologies) (Table S1, Supplementary Materials).
+ Open protocol
+ Expand

Corresponding organizations : University of Bari Aldo Moro, Gastroenterology Hospital "Saverio de Bellis", University of Salerno

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!

🧪 Need help with an experiment or choosing lab equipment?
I search the PubCompare platform for you—tapping into 40+ million protocols to bring you relevant answers from scientific literature and vendor data.
1. Protocol search & design
(papers, patents, application notes)
2. Protocol validation
(from literature and MDAR)
3. Lab Product search
4. Product validation from literature
5. Troubleshoot product/ protocol
6. Instant figure generation New
Want to copy this response? Create your account to unlock copy/paste and export options.